Genmab (Otc) (GMAB)

NASDAQ:GMAB

US Market

GMAB

Genmab

RESEARCH TOOLSreports

Genmab (GMAB) Ownership - Who Owns Genmab?

778 Followers

Genmab (GMAB) Ownership Overview

0.81% Mutual Funds

4.83% Other Institutional Investors

1.11% ETFs

93.25% Public Companies and Individual Investors

The ownership structure of Genmab (GMAB) stock is a mix of institutional, retail, and individual investors. Approximately 6.75% of the company’s stock is owned by Institutional Investors, and 93.25% is owned by Public Companies and Individual Investors.

The ownership structure of Genmab (GMAB) stock is a mix of institutional, retail, and individual investors. Approximately 5.94% of the company’s stock is owned by Institutional Investors, 0.81% is owned by Insiders, and 93.25% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2025	Manning & Napier Advisors Llc	xxxxxxxxxxxxx	$2217
Dec 31, 2025	Gallacher Capital Management Llc	xxxxxxxxxxxxx	$664202
Dec 31, 2025	Woodline Partners Lp	xxxxxxxxxxxxx	$11370990

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	3,699,612	Institution	0.58%	96,707,858
	2,744,130	Institution	0.43%	71,731,558
	2,473,892	Institution	0.39%	64,667,537
	707,500	Institution	0.11%	18,494,050
	493,393	Institution	0.08%	12,897,293
	425,272	Institution	0.07%	11,116,610
Michael Rockefeller	369,188	Institution	0.06%	9,650,574
	362,815	Institution	0.06%	9,483,984
	195,954	Institution	0.03%	5,122,238
	179,676	Institution	0.03%	4,696,731

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	2,744,130	Institution	0.43%	71,731,558
	707,500	Institution	0.11%	18,494,050
	425,272	Institution	0.07%	11,116,610
	362,815	Institution	0.06%	9,483,984
	195,954	Institution	0.03%	5,122,238
	179,676	Institution	0.03%	4,696,731
	179,130	Institution	0.03%	4,682,458
	142,000	Institution	0.02%	3,711,880
	47,510	Institution	<0.01%	1,241,911
	41,260	Institution	<0.01%	1,078,536

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Biotechnology ETF	3,566,186	Institution	0.56%	93,220,102
First Trust NYSE Arca Biotechnology Index Fund	2,374,851	Institution	0.37%	62,078,605
Avantis International Equity ETF	454,562	Institution	0.07%	12,077,712
Tema Oncology ETF	178,924	Institution	0.03%	4,754,011
Fidelity Enhanced International ETF	150,361	Institution	0.02%	4,116,884
First Trust Hedged BuyWrite Income ETF	71,494	Institution	0.01%	1,868,853
iShares NASDAQ US Biotechnology UCITS ETF	42,689	Institution	<0.01%	1,134,247
ActivePassive International Equity ETF	38,902	Institution	<0.01%	1,033,626
AdvisorShares Dorsey Wright ADR ETF	33,093	Institution	<0.01%	865,051
Dimensional International Core Equity Market ETF	22,620	Institution	<0.01%	601,013

FAQ

Who Owns Genmab (Otc) (GMAB)?

Currently, no data Available

What percentage of Genmab (Otc) (GMAB) stock is held by institutional investors?

According to the latest TipRanks data, approximately 4.83% of Genmab (Otc) (GMAB) stock is held by institutional investors.

What percentage of Genmab (Otc) (GMAB) stock is held by retail investors?

According to the latest TipRanks data, approximately 93.25% of Genmab (Otc) (GMAB) stock is held by retail investors.

Who owns the most shares of Genmab (Otc) (GMAB)?

iShares owns the most shares of Genmab (Otc) (GMAB).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.